Ventas (VTR) Projected to Post Quarterly Earnings on Tuesday

Key Points

• Ventas is expected to report Q3 2026 results after Tuesday’s market close, with analysts forecasting earnings of $0.1621 per share and revenue of $1.77 billion. The earnings call is scheduled for October 27 at 10:00 a.m. ET.
• In its previous quarter, Ventas beat analyst expectations with $0.97 EPS and $1.73 billion in revenue, while revenue increased 21.7% year over year.
• Shares recently traded at $84.56, down 1.5%, while analysts maintain a “Moderate Buy” consensus and an average price target of $98.33. Ventas also pays a quarterly dividend of $0.52 per share, representing a 2.5% yield.

Ventas (NYSE:VTR - Get Free Report) is anticipated to issue its Q3 2026 results after the market closes on Tuesday, October 27th. Analysts expect Ventas to announce earnings of $0.1621 per share and revenue of $1.77 billion for the quarter. Individuals are encouraged to explore the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, October 27, 2026 at 10:00 AM ET.

Ventas (NYSE:VTR - Get Free Report) last released its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%. The firm had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the company posted $0.87 earnings per share. The business's revenue was up 21.7% on a year-over-year basis. On average, analysts expect Ventas to post $3.89 EPS for the current fiscal year and $4.29 EPS for the next fiscal year.

Ventas Trading Down 1.5%

Shares of VTR stock opened at $84.56 on Tuesday. The company has a market capitalization of $43.38 billion, a P/E ratio of 156.60, a price-to-earnings-growth ratio of 3.35 and a beta of 0.72. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. The business's 50 day moving average is $88.13 and its two-hundred day moving average is $88.00. Ventas has a twelve month low of $68.15 and a twelve month high of $101.60.

Ventas Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th were paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Wednesday, September 30th. Ventas's dividend payout ratio (DPR) is 385.19%.

Analysts Set New Price Targets

Several brokerages recently weighed in on VTR. Cantor Fitzgerald boosted their target price on shares of Ventas from $97.00 to $102.00 and gave the company an "overweight" rating in a research note on Friday, July 31st. Scotiabank upped their target price on shares of Ventas from $93.00 to $95.00 and gave the company a "sector perform" rating in a report on Wednesday, September 2nd. Wells Fargo & Company decreased their price target on shares of Ventas from $104.00 to $96.00 and set an "overweight" rating on the stock in a research note on Monday. BMO Capital Markets raised their price target on shares of Ventas from $105.00 to $107.00 and gave the stock an "outperform" rating in a research note on Tuesday, August 11th. Finally, Evercore set a $100.00 price target on shares of Ventas in a report on Monday, September 21st. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $98.33.

About Ventas

Ventas, Inc NYSE: VTR is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.

Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.